Global Breast Imaging Market - 2025-2033

The global breast imaging market reached US$ 4.74 billion in 2024 and is expected to reach US$ 9.77 billion by 2033, growing at a CAGR of 8.43% during the forecast period 2025-2033.

Breast imaging encompasses a variety of diagnostic techniques aimed at visualizing and evaluating breast tissue to identify abnormalities such as lumps, cysts, or signs of breast cancer. These methods are essential for early detection, diagnosis, and monitoring of breast conditions, thereby facilitating timely and effective treatment interventions.

Market Dynamics: Drivers & Restraints

Rising technological advancements

Advancements in breast imaging technologies are significantly propelling market growth by enhancing diagnostic accuracy, improving patient outcomes, and increasing accessibility. Technologies like digital mammography, 3D tomosynthesis, and AI-enhanced imaging enable earlier and more precise detection, even in dense breast tissue, while minimizing false positives. For instance, in August 2024, OSF HealthCare introduced the Invenia ABUS 2.0 (Automated Breast Ultrasound System) at its Saint Elizabeth Medical Center in Peru, marking a significant technological advancement in breast cancer screening. The Invenia ABUS 2.0 is specifically designed to detect cancers that may be hidden on mammograms due to the density of breast tissue, where both dense tissue and cancerous masses appear white.

Similarly, in June 2022, Seno Medical's Imagio Breast Imaging System received supplemental premarket approval (PMA) from the Center for Devices and Radiological Health (CDRH) of the US Food & Drug Administration (FDA). The Imagio Breast Imaging System by Seno Medical represents a significant technological advancement in breast imagingThis innovative system utilizes a combination of opto-acoustic (OA) and ultrasound (US) technologies to provide real-time information about breast lesions.

Additionally, the demand for advanced solutions is surging as healthcare providers and patients recognize the importance of early and accurate diagnosis. As technology progresses, access to high-quality imaging is improving globally, including in underserved regions. Continuous research into new imaging modalities and AI applications further propels market growth, ensuring more women can benefit from early detection initiatives and fostering ongoing advancements in breast cancer detection and treatment.

High costs associated with breast imaging systems

The high costs associated with breast imaging systems present a significant challenge to the growth of the market. For instance, digital mammography systems can range from $65,000 to $95,000, depending on the model and manufacturer. The high upfront investment required for purchasing and maintaining equipment such as digital mammography machines, MRI systems, and 3D tomosynthesis devices can be a significant financial burden for hospitals, clinics, and healthcare providers.

Segment Analysis

The global Breast Imaging market is segmented based on technology, end-user, and region.

Technology:

Magnetic resonance imaging (MRI) segment is expected to dominate the global Breast Imaging market share

The Magnetic Resonance Imaging (MRI) segment dominates the breast imaging market due to its advanced imaging capabilities and non-invasive nature. Innovations such as 3D MRI and contrast-enhanced MRI significantly enhance the effectiveness of breast cancer detection, particularly for women with dense breast tissue or those at high risk. For instance, in October 2022, Intermountain Healthcare is launching an abbreviated MRI screening tool specifically designed for women at higher risk of developing breast cancer. This development marks a significant advancement in the MRI segment of breast imaging, as it offers a targeted approach to enhance early detection in populations that may not benefit as much from traditional mammography. These advancements allow healthcare providers to deliver more accurate and detailed diagnostic options, leading to improved patient outcomes. The high sensitivity and specificity of MRI are crucial for early detection and effective management of breast cancer, making it a preferred choice in clinical settings.

The increasing prevalence of breast cancer drives the adoption of MRI in breast imaging. According to the World Health Organization report, In 2022, there were 2.3 million women diagnosed with breast cancer. The incidence is expected to increase which is increasing the urgent need for advanced imaging technologies like MRI. As healthcare systems emphasize early detection and preventive care, the demand for MRI continues to rise, positioning it as a leading segment in the breast imaging market. The combination of technological advancements and growing awareness about breast cancer screening underscores MRI's pivotal role in enhancing diagnostic capabilities and improving patient care.

Geographical Analysis

North America is expected to hold a significant position in the global breast imaging market share

North America is expected to hold a significant position in the global breast imaging market due to several key factors. Advancements in medical technology, particularly in imaging techniques like 3D mammography, ultrasound, and MRI, are crucial factors in maintaining North America's dominant position in the breast imaging market. As these technologies evolve, healthcare providers in the region can offer more precise, non-invasive, and effective diagnostic options.

The region's continued development of cutting-edge technologies helps solidify its leadership in the global breast imaging market, ensuring that healthcare providers have access to the latest tools for early detection and improved treatment. For instance, Seno Medical Instruments officially launched the commercially available Imagio Breast Imaging System at RSNA in November 2022, marking a significant development for breast cancer diagnostics in North America. This innovative system utilizes a combination of optoacoustic and ultrasound technology to provide real-time information about breast lesions, enabling radiologists to differentiate between benign and malignant masses more effectively.

Key market players are driving the growth of the breast imaging market in North America by focusing on technological advancements, strategic partnerships, and expanding their product portfolios. For instance, in December 2024, QT Imaging Holdings, Inc. announced the expansion of its Breast Acoustic CT Scanner to the Couri Center for Gynecology and Integrative Women's Health in Peoria, IL. This strategic initiative, executed in partnership with NXC Imaging, Inc., enhances access to innovative breast imaging technology that prioritizes patient comfort and safety while delivering high-quality diagnostic capabilities. The rising demand for breast imaging in both diagnostic and treatment applications has created significant growth opportunities for manufacturers in North America. Thus, the above factors are expected to hold the region in the dominant position.

Competitive Landscape

The major global players in the Breast Imaging market include Bayer AG, Pfizer, Inc., AbbVie, Inc, AstraZeneca, Gedeon Richter Plc., TORRENT PHARMACEUTICALS LTD., Sanofi SA, Gynogen, and Weefsel Pharma among others.

Key Developments

• In August 2024, Izotropic Corporation announced that it is pursuing a regulatory strategy in the U.S. and EU to launch IzoView as a diagnostic device indicated for use in patients with dense breast tissue.
• In June 2023, Koning Corporation launched adjunctive artificial intelligence (AI) software that can produce 3D CT breast images through seamless integration with the company's existing breast CT devices.
• In January 2023, Izotropic Corporation announced that IzoView will be featured on an upcoming segment of Advancements with Ted Danson ("Advancements") via Amazon Prime Video and Bloomberg TV.

Why Purchase the Report?

• Pipeline & Innovations: Reviews ongoing clinical trials, and product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
• Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
• Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
• Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
• Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
• Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
• Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
• Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
• Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
• Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
• Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
• Post-market Surveillance: Uses post-market data to enhance product safety and access.
• Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The Global Breast Imaging Market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

• Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
• Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
• Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
• Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
• Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
• Supply Chain: Distribution and Supply Chain Managers.
• Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
• Academic & Research: Academic Institutions.